Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
2017/06/09Number of shares and voting rights of ADOCIA as of May 31, 2017
2017/05/19Adocia to hold its annual shareholders’ meeting on June 27, 2017 in Paris
19-23 June, 2017 Bio International Convention, San Diego, CA, USA - The BIO International Convention (BIO) attracts 16,000+ biotechnology and pharma leaders who come together for one week of intensive networking to discover new opportunities and promising partnerships. We bring together a wide spectrum of life science and application areas including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology and cell therapy.